Clinical Trial Update: Biomarkers and Choroidal Neovascularization

View source ↗

Summary

This entry describes an INSERM-led clinical trial in France investigating biomarkers for Choroidal Neovascularization and Mineralocorticoid Excess; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Neovascularization
• Mineralocorticoid Excess

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Choroidal Neovascularization, Mineralocorticoid Excess | Status: ACTIVE_NOT_RECRUITING